ERCC1 induction after oxaliplatin exposure may depend on KRAS mutational status in colorectal cancer patient: preliminary data from liquid biopsy.

11033 Background: Basing on preliminary observations of OPUS and PRIME studies, our group retrospectively suggested that KRAS mutational status could affect response to oxaliplatin. We further conf...